RSCP

"RSCP" is an acronym used in various contexts, leading to non-specificity. In the provided clinical and scientific literature, it refers to several distinct entities, including medical procedures (Robotic Sacrocolpopexy), medical devices (Robotic Spinal Cord Probe), and educational programs (Radiology Scholars Certificate Program). In the context of drug development, "RSCP NPs" refers to novel red light-responsive biomimetic nanoparticles. These nanoparticles are engineered for targeted delivery of multiple therapeutic agents, such as astaxanthin and rosiglitazone, to specific cellular microenvironments, including M1-like macrophages and white adipocytes. Their mechanism involves utilizing red light signaling and pH differences to precisely deliver these agents, aiming to alleviate obesity-induced insulin resistance and other metabolic disorders by reducing inflammation and promoting white adipocyte browning.

Other names

Red light-responsive biomimetic nanoparticles